ATE438721T1 - Hp90:wirtsrezeptor für pathogene bakterien - Google Patents

Hp90:wirtsrezeptor für pathogene bakterien

Info

Publication number
ATE438721T1
ATE438721T1 AT98954076T AT98954076T ATE438721T1 AT E438721 T1 ATE438721 T1 AT E438721T1 AT 98954076 T AT98954076 T AT 98954076T AT 98954076 T AT98954076 T AT 98954076T AT E438721 T1 ATE438721 T1 AT E438721T1
Authority
AT
Austria
Prior art keywords
tir
polypeptide
coli
receptors
antibodies
Prior art date
Application number
AT98954076T
Other languages
German (de)
English (en)
Inventor
B Finlay
Brendan Kenny
Rebekah Devinney
Marcus Stein
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE438721T1 publication Critical patent/ATE438721T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98954076T 1997-11-12 1998-11-10 Hp90:wirtsrezeptor für pathogene bakterien ATE438721T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6513097P 1997-11-12 1997-11-12
PCT/CA1998/001042 WO1999024576A1 (en) 1997-11-12 1998-11-10 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene

Publications (1)

Publication Number Publication Date
ATE438721T1 true ATE438721T1 (de) 2009-08-15

Family

ID=22060539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954076T ATE438721T1 (de) 1997-11-12 1998-11-10 Hp90:wirtsrezeptor für pathogene bakterien

Country Status (9)

Country Link
EP (1) EP1029054B1 (enExample)
JP (2) JP4410412B2 (enExample)
AT (1) ATE438721T1 (enExample)
AU (1) AU1137399A (enExample)
CA (1) CA2309559A1 (enExample)
DE (1) DE69841042D1 (enExample)
ES (1) ES2333630T3 (enExample)
PT (1) PT1029054E (enExample)
WO (1) WO1999024576A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901897D0 (en) * 1999-01-29 1999-03-17 Imp College Innovations Ltd Biological material and use thereof
GB0013115D0 (en) * 2000-05-31 2000-07-19 Imp College Innovations Ltd Biological materials and methods for use in the prevention or treatment of infections
WO2002053181A1 (en) 2001-01-04 2002-07-11 University Of Saskatchewan Enterohemorragic escherichia coli vaccine
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
CN1922324B (zh) 2003-10-31 2010-06-09 不列颠哥伦比亚大学 细菌毒力因子及其用途
US8414903B2 (en) 2006-11-29 2013-04-09 Tufts University Escherichia coli mutants and methods of use thereof
WO2010115278A1 (en) 2009-04-06 2010-10-14 University Of Saskatchewan Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
AU2014225717B2 (en) * 2013-03-07 2019-01-17 President And Fellows Of Harvard College Compositions and methods for bacterial delivery of polypeptides
US10702559B2 (en) 2016-02-09 2020-07-07 The General Hospital Corporation Methods and compositions relating to engineered microbial cells

Also Published As

Publication number Publication date
ES2333630T3 (es) 2010-02-24
EP1029054B1 (en) 2009-08-05
DE69841042D1 (de) 2009-09-17
JP2009173667A (ja) 2009-08-06
CA2309559A1 (en) 1999-05-20
JP2001522605A (ja) 2001-11-20
PT1029054E (pt) 2009-11-11
JP4410412B2 (ja) 2010-02-03
EP1029054A1 (en) 2000-08-23
AU1137399A (en) 1999-05-31
WO1999024576A1 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
Cunningham et al. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.
CA2365898A1 (en) Ibd-associated microbial antigens and methods of using same
BR9710433A (pt) Proteínas associada a escherichia coli patogênica
CA2180425A1 (en) Purified primate ctla-8 antigens and related reagents
DE69841042D1 (de) HP90:WIRTSREZEPTOR FüR PATHOGENE BAKTERIEN
CA2328803A1 (en) Anti-procalcitonin antibodies and the preparation and use thereof
EP0896583A1 (en) Novel osp-c derived peptide fragments
CA2343979A1 (en) Human interleukin-b50, therapeutic uses
US6716574B2 (en) Osp-C derived peptide fragments
WO2008119358A2 (en) Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
EP0914438A1 (en) Recombinant sef14 fimbrial protein from salmonella
CA2240409A1 (en) Mammalian cx3c chemokine genes
Chaemchuen et al. Identification of candidate host proteins that interact with LipL32, the major outer membrane protein of pathogenic Leptospira, by random phage display peptide library
US5254459A (en) Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom
Huang et al. Host focal adhesion protein domains that bind to the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC)
CA2451347A1 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
Jarvis et al. Structure of the cell wall of Staphylococcus aureus. VIII. Structure and chemical synthesis of the basic peptides released by the Myxobacterium enzyme
JP2001522605A5 (enExample)
EP0726314A1 (en) FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS)
SE446867B (sv) Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US7595059B2 (en) Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen
EP2561362B1 (de) Verfahren zur erkennung einer salmonelleninfektion
Anderson et al. The structure of a repressor: crystallographic data for the Cro regulatory protein of bacteriophage λ
US5476767A (en) Isolated nucleic acid molecule coding for toxin associated with Kawasaki Syndrome and uses thereof
Brierley et al. Products of the polymerase-encoding region of the coronavirus IBV

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1029054

Country of ref document: EP